Clinical Trial: Evaluation of the Efficacy and Safety of Tegoprazan-Doxycycline Dual Therapy for First-Line Helicobacter pylori Eradication: A Multicenter, Randomized Controlled Clinical Study. (China)

China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of the Efficacy and Safety of Tegoprazan-Doxycycline Dual Therapy for First-Line Helicobacter pylori Eradication: A Multicenter, Randomized Controlled Clinical Study.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135620

Registration Time: 2026/10/30

Type: Interventional study

Primary Sponsor: Ningbo Medical Centre Lihuili Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346616

Published by HT Digital Content Services with permission from Health Daily Digest....